Inflazyme Pharmaceuticals (T.IZP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Chuca Marsh who wrote (1223)	4/20/1999 9:21:00 AM
From: Chuca Marsh	Read Replies (1) of 1501

G & M Story this AM: Globe says Inflazyme, Cortecs terminate licencing agreement Inflazyme Pharmaceuticals Ltd IZP Shares issued 24,997,493 1999-04-19 close $1.35 Tuesday Apr 20 1999 The Globe and Mail reports in its Tuesday, April 20, edition that Inflazyme Pharmaceuticals and Britain's Cortecs Diagnotics have terminated their 1996 licencing agreement to develop and commercialize products to diagnose tuberculosis. The Globe's News Bulletins column reports that the move reflects a decision this year by Cortecs to streamline its operations, including termination of several scientific collaborations. The tuberculosis technology in the venture will be returned to Inflazyme, reports The Globe. (c) Copyright 1999 Canjex Publishing

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next